Goodwill and Other Intangible Assets

12 Months Ended

Jun. 30, 2012

Goodwill and Other Intangible Assets [Abstract]

(7)	Goodwill and Other Intangibles

Goodwill and other intangibles presented below have been allocated to the Company's operating segments.

a. Goodwill

Changes in the carrying amount of goodwill, by reportable segment, during the years ended June 30 are as follows:

				Globe
	GMI			Metales		Solsil			Other		Total
Balance at June 30, 2010
Goodwill	$	30,405			14,313		57,656			7,307		109,681
Accumulated impairment loss		—			—		(57,656	)		—		(57,656	)
		30,405			14,313		—			7,307		52,025
Core Metals purchase price allocation adjustments		1,124			—		—			—		1,124
Foreign exchange rate changes		—			—		—			354		354
Balance at June 30, 2011
Goodwill		31,529			14,313		57,656			7,661		111,159
Accumulated impairment loss		—			—		(57,656	)		—		(57,656	)
		31,529			14,313		—			7,661		53,503
Quebec Silicon acquisition		3,063			—		—			—		3,063
Foreign exchange rate changes		(1	)		—		—			175		174
Balance at June 30, 2012
Goodwill		34,591			14,313		57,656			7,836		114,396
Accumulated impairment loss		—			—		(57,656	)		—		(57,656	)
	$	34,591			14,313		—			7,836		56,740

b. Other Intangible Assets

There were no changes in the value of the Company's indefinite lived intangible assets during the years ended June 30, 2012 or 2011. The trade name balance is $477 at June 30, 2012 and 2011.

Amortization expense of purchased intangible assets for the years ended June 30, 2012, 2011 and 2010 was $0, $0 and $310, respectively, which is recorded in cost of goods sold. The carrying amount of definite lived intangible assets at both June 30, 2012 and June 30, 2011 is $0.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details